AMERIS BAN ($ABCB) posted quarterly earnings results for Q1 2026 on Thursday, April 23rd. The company reported earnings of $1.63 per share, beating estimates of $1.59 by $0.04. The company also reported revenue of $315,300,000, missing estimates of $315,518,844 by $-218,844.
You can see Quiver Quantitative's $ABCB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AMERIS BAN Insider Trading Activity
AMERIS BAN insiders have traded $ABCB stock on the open market 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $ABCB stock by insiders over the last 6 months:
- JAMES A LAHAISE (Chief Strategy Officer) sold 6,641 shares for an estimated $550,738
- WILLIAM H STERN purchased 307 shares for an estimated $23,749
- DOUGLAS D STRANGE (Chief Credit Officer) has made 0 purchases and 2 sales selling 205 shares for an estimated $14,728.
- ROSS L CREASY (Chief Information Officer) sold 0 shares for an estimated $42
- NICOLE S STOKES (CFO) sold 0 shares for an estimated $41
- LEO J HILL has made 0 purchases and 2 sales selling 0 shares for an estimated $25.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AMERIS BAN Hedge Fund Activity
We have seen 182 institutional investors add shares of AMERIS BAN stock to their portfolio, and 168 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORTH REEF CAPITAL MANAGEMENT LP added 755,967 shares (+38.2%) to their portfolio in Q4 2025, for an estimated $56,145,669
- AMERICAN CENTURY COMPANIES INC removed 723,822 shares (-38.5%) from their portfolio in Q4 2025, for an estimated $53,758,259
- MILLENNIUM MANAGEMENT LLC removed 645,474 shares (-96.3%) from their portfolio in Q4 2025, for an estimated $47,939,353
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. added 541,995 shares (+inf%) to their portfolio in Q1 2026, for an estimated $42,270,190
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 459,632 shares (-75.6%) from their portfolio in Q4 2025, for an estimated $34,136,868
- FMR LLC added 419,879 shares (+75.6%) to their portfolio in Q4 2025, for an estimated $31,184,413
- JENNISON ASSOCIATES LLC added 414,920 shares (+31.3%) to their portfolio in Q4 2025, for an estimated $30,816,108
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AMERIS BAN Congressional Stock Trading
Members of Congress have traded $ABCB stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ABCB stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 01/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
AMERIS BAN Analyst Ratings
Wall Street analysts have issued reports on $ABCB in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- DA Davidson issued a "Buy" rating on 11/25/2025
- Piper Sandler issued a "Overweight" rating on 10/29/2025
To track analyst ratings and price targets for AMERIS BAN, check out Quiver Quantitative's $ABCB forecast page.
AMERIS BAN Price Targets
Multiple analysts have issued price targets for $ABCB recently. We have seen 6 analysts offer price targets for $ABCB in the last 6 months, with a median target of $86.5.
Here are some recent targets:
- John McDonald from Truist Securities set a target price of $86.0 on 02/02/2026
- Gary Tenner from DA Davidson set a target price of $94.0 on 02/02/2026
- Russell Gunther from Stephens & Co. set a target price of $87.0 on 02/02/2026
- Catherine Mealor from Keefe, Bruyette & Woods set a target price of $88.0 on 02/02/2026
- Stephen Scouten from Piper Sandler set a target price of $84.0 on 10/29/2025
- David Feaster from Raymond James set a target price of $80.0 on 10/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
